We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Can Organ-on-a-Chip Technology Really Replace Animal Testing of Drug and Chemical Safety

Video   Oct 18, 2016

 

There is currently great interest in applying microfluidics technology to the construction of complex in vitro models with the eventual goal of simulating the behaviour of an organ or even a whole organism. The enthusiasm for microtechnology has been generated by past success in scaling cell culture from a petri dish down to the current multiple well plates. However our gold standard for clinical response is the human body, which incorporates functional units that require larger scale. It is widely recognised that 3D cell cultures are more representative of human physiology than 2D monolayers of cells growing on a flat surface. Correct organ function also requires gradients of oxygen and metabolites and removal of waste material, as well as co-culture of multiple cell types- hence advanced and accurate models also require flow of media. Any technology which aims to replace animal based methods for safety and toxicity testing will have to meet the following requirements: •Systemic models •Long term and repeat dose exposure •Maintain homeostasis (before insult) •Good disease models The goal for organ-on-a- chip is to accurately mimic clinical behaviour. Once this milestone is achieved then models must demonstrate robustness, repeatability and ease of use, and be economic compared with alternative methods. It is suggested here that the currently available meso-scale Quasi Vivo® technology is a useful stepping stone on the route to the ultimate micro-scale miniaturisation, by acting as a physiologically relevant ‘breadboarding’ tool to aid development of co-culture and long term models with full metabolic capability.

 
 
 
Advertisement
 

Recommended Videos

Quick guide to performing large-scale evaporation

Video

Benefit form a live demonstration of how to use industrial evaporator

WATCH NOW

2C or Not 2C: CYP2C Induction Studies for Successful Preclinical Risk Assessment (Webinar)

Video

This webinar will focus on CYP2C induction and will emphasize when to include CYP2C induction in a study, how to design the study to generate meaningful data and meet the regulatory requirements, what endpoints to measure, and how to interpret results.

WATCH NOW

Brain Organoids With Dr Christopher Esk

Video

This installment of Teach Me in 10 features Dr Christopher Esk, a postdoctoral fellow at the Institute of Molecular Biotechnology in Vienna, Austria. In this episode Esk talks about the systematic analysis of human brain tissue development using cerebral organoids.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE